Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab-MMAE)
Catalog No.
F2039
Anti-ERBB2/HER2/CD340 Antibody (Trastuzumab-MMAE)
Featured Products
Trastuzumab MMAE is an antibody-drug conjugate (ADC) consisting of the anti-HER2 antibody trastuzumab coupled to monomethyl auristatin E (MMAE) via a Mc linker. Trastuzumab MMAE has the potential to be used in solid tumor research, mainly HER2-positive breast cancer.
145 kDa
Dry ice
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
trastuzumab-MMAE
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P04626
Human
MMAE
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human HER2 His at 2 ug/mL can bind Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab-MMAE), EC50 is 0.008281 ug/mL.
ERBB2 / HER2 / CD340
Please avoid freeze-thaw cycles.